SlideShare a Scribd company logo
1 of 56
Download to read offline
1
SUBMITTED BY
JISNA SEBASTIAN
FIRST YEAR MPHARM 2
3
The term derived from Greek word ‛Para’ outside &
‛Enterone’ intestine.
Parenterals are sterile solutions or suspension of drug in
aqueous or oily vehicle.
Parenteral drugs are administered directly in to the
veins, muscles or under the skin , or more specialized
tissues such as spinal cord.
Term parenteral used for any drug/fluid whose delivery
doesn’t utilize the alimentary canal for entering in to the
body tissues.
4
• Stability
• Sterility
• Free from pyrogens & toxins
• Free from foreign particles
• Isotonic
• Chemical purity
5
PARENTERAL ROUTES
The term parenteral literally means to avoid the
gut (gastrointestinal tract) and refers to any route of
administration outside of or beside the alimentary tract.
Thus, parenterals are injectable drugs that enter the body
directly and are not required to be absorbed in the
gastrointestinal tract before they show their effect.
Parenteral routes of administration usually have a more rapid
onset of action than other routes of administration.
6
1. Intravenous
2. Intramuscular
3. Subcutaneous
4. intradermal
5. Intra-arterial
6. Intracardiac
7. Intrathecal
8. Intracisternal
9. Peridural
10.Intraarticular
11.Intracerebral
PARENTERAL ROUTES
Intravenous
• The injection of a drug
directly into the patient's
veins, resulting in the
most rapid onset of action.
7
8
Intradermal
The drug is injected into the top
few layers of the skin. Ideally,
the drug is placed within the
dermis. Used for diagnostic
agents.
Subcutaneous
The injection of the drug under
the skin into the fatty layer,
but not into the muscle.
Absorption of the drug is rapid.
Eg; insulin
9
Intramuscular
Drugs are injected deeply into
muscle tissue. If the drug is in
aqueous (water) solution,
absorption is rapid. However, if
the drug is in an oily liquid or in
the form of a suspension, it can
prolong the release of the drug.
10
11
12
Useful for patients who cannot take drugs orally
Rapid onset of action
Useful for emergency situations
Providing sustained drug delivery (implants, im depot inj)
Avoid first pass metabolism
Can inject drug directly in to a tissue (target drug delivery)
Useful for delivering fluids, electrolytes, or nutrients (TPN)
Can be done in hospitals, ambulatory infusion centers and
home health care centers
Complete bioavailability.
13
Pain on injection
Difficult to reverse an administered drug’s effect.
Sensitivity or allergic reaction at the site of injection.
Requires strict control of sterility & non pyrogenicity than
other formulation.
Trained person is required.
Require specialized equipment, devices, and techniques
to prepare and administer drugs.
More expensive and costly to produce.
14
1. Small volume parenterals (SVP)
2. Large volume parenterals (LVP)
15
USP defn: An injection that is packed in containers labeled as
containing 100 ml or less.
Defn: LVP are parenterals designed to provide :-
Fluid
Calories (dextrose solution )
Electrolytes
Combenation of these
Volume 101- 1000 ml
16
parameter SVP LVP
volume 100 ml or less 101-1000 ml
Routes IV, IM & SC IV- LVP & non IV- LVP
Dosage unit Single or multiple Single
preservative Used Not used
Buffers Used Not used
Formulation Soln, emulsion,suspension. Soln & o/w nutrient
emulsion
Isotonicity Not essential must
Pyrogenicity Not essential must
use Therapeutic & diagnostic Nutrition,detoxification,
And during surgery
17
AQUEOUS VEHICLE :
WATER FOR INJECTION (WFI) USP :
Highly purified water used as a vehicle for injective
preparations which will be subsequently sterilized.
USP requirement include not more than 10 parts per million
of total solids.
pH of 5.0 – 7.0 .
WFI may be prepared by either distillation or reverse osmosis.
 Stored in chemically resistant tank.
18
BACTERIOSTATIC WATER FOR INJECTION
This type of water used for making parenteral
solutions prepared under aseptic conditions and not
terminally sterilized.
Need to meet USP sterility test.
It can contain an added bacteriostatic agent when
in containers of 30 ml or less.
19
STERILE WATER FOR INJECTION
SWFI containing one or more suitable bacteriostatic agent.
 multiple – dose containers not exceeding 30 ml.
They are permitted to contain higher levels of solid than
WFI because of possible leaching.
Used for washing wounds , surgical incisions, or body
tissues.
20
WATER MISCIBLE VEHICLES
The number of solvents that are miscible with water has
been used as a portion of a vehicle.
Primarily to affect solubility of drugs and to reduce
hydrolysis.
Example:
Ethyl alcohol,
Liquid propelene glycol
Glycerine
Ethyl alcohol used in the case of cardiac glycoside.
21
NON – AQUEOUS VEHICLES
Fixed oils (vegitable origin, liquid, and rancid resistance
,unsaturated, free fatty acid content )
Peanut oil
Corn oil
Cotton seed oil (depo-testosterone)
Sesame oil
Soyabean oil
Ethyl oleate
Isopropyl myristate.
22
ANTIBACTERIAL AGENTS
These are added in multiple dose containers.
To prevent microorganism growth
Limitted concenteration of agents are used.
Phenyl mercuric nitrate and thiomersol 0.01%.
Benzethonium chloride & benzalkonium chloride 0.01%.
Phenol & cresol 0.05%.
Chlorobutanol 0.05%.
23
BUFFERS
Added to maintain pH.
To stabilize a solution from chemical degradation.
Citrate and acetate buffer.
Sodium benzoate and benzoic acid
Sodium tartarate and tartaric acid
Phosphate buffer.
24
ANTIOXIDENT
To protect the formulation from oxidation
Two types
1. Reducing agents
Ascorbic acid
Sodium bisulfite 0.01%
Thiourea
2.Blocking agents
Tocopherol
25
SURFACTANTS
 Solubilise the active ingredient
Polyoxythylene sorbitan monooleate & Sorbitan
monooleate TONICITY AGENTS
Need isotonic solution to avoid destruction of red blood
cells, irritation, and tissue damage
 More important for large volumes, rapidly administered,
and extravascular injections
 Reduces the pain on injection
NaCl & KCl
Dextrose
Mannitol & Sorbitol Effect of different solutions on blood cells
CHELATING AGENTS
 To remove trace elements that catalyse oxidative
degeneration
Ethelene diamine tetra acetic acid
26
CO-SOLVENT
 Improve solubility
 Prevent potential for hydrolysis
27
BULKING AGENTS
 For freeze dried preparations(solids)
Mannitol
Lactose ,sucrose
Dextran .
SUSPENDING AGENTS
CMC,
Methyl cellulose, Gelatin
Sorbitol .
EMULSIFYING AGENTS
Lecithin
Polysorbate 80
 A clear and colorless liquid; odorless.
 Water for injections is pyrogen -free.
 It contains no added substance.
 Water for injections is obtained from potable or Purified
water by distillation in an apparatus.
 The distillate is collected and stored in conditions
designed to prevent growth of microorganisms and to
avoid any other contamination.
28
• The source water usually must be pretreated by one
or a combination of following treatment:
• Chemical softening, filtration, deionization, carbon
absorption, or reverse osmosis purification.
• There are three types of distillation still to produce
water for injection.
1. Compression distillation
2. Multiple-effect still
3. Reverse osmosis
29
• Vapor compression still is primarily designed for the
production of large volumes of high purity distillate with low
consumption of energy and water.
• Vapor compression processes produce water 5 to 10 times
more cost effectively than multiple effect distillers.
• PROCEDURE:
• Step 1: In a Vapor Compression still, the boiling process
begins with both heating elements turned on. As the water in
the boiling chamber reaches near boiling temperatures, the
compressor turns on.
30
• Step 2: In the compressor, the steam is pressurized, which
raises the steam's temperature before it is routed through a
special heat exchanger located inside the boiling chamber.
• Step 3: The pressurized steam gives off its heat to the tap
water inside the boiling chamber, causing this water to boil,
which creates more steam.
31
• Step 4: While the pressurized steam is giving up its
latent heat, the steam will condense. One of the
heating elements will cycle on and off periodically as
needed.
• Step 5: At this stage, the condensed steam is
considered distilled water but is still very hot--only
slightly cooler than boiling temperature.
32
33
COMPRESSION STILL
• It is also designed to conserve energy and water usage.
• In principle, a series of single effect stills running at different
pressures.
• A series up to seven effect may be used, with the first effect
operated at a highest pressure and the last effect at
atmospheric pressure.
• The capacity of still can be increased by adding effects. The
quantity of distillate will also be affected by inlet steam
pressure 34
PRODEDURE:
 Steam from the external source is used in the first effect
to generate steam under pressure from feed water, it is
used as a power source for second effect.
 The steam used to drive the second effect condenses
as it gives up its heat of vaporization and forms a
distillate.
 The process continues until the last effect, when the
steam is at atmospheric pressure and must be
condensed in a heat exchanger. 35
36
REVERSE OSMOSIS:
• The natural process of selective permeation of molecule
through a semi-permeable membrane separate two aqueous
solutions of different concentration is reversed.
• Pressure, usually between 200 to 400 psig, is applied to
overcome osmotic pressure and force pure water to
penetrate through the membrane.
• Membrane composed of cellulose esters or polyamides.
37
38
•. It provide effective rejection of contaminant molecules in
raw water.
•Sodium chloride is most difficult to remove.
•Passage through two membranes in series is sometimes
used to increase the efficiency of removal of small
molecules.
• ex. Aqua chem , Finn-aqua, Meco , Milipore etc.
39
STORAGE AND DISTRIBUTION
• Distillate is collected in holding tanks for subsequent use.
• USP permit the storage of WFI at room temp. maximum for
only about 24hr.
• When the water can not be used at 80º c , heat exchangers
must be installed to reduce the temperature at the point of
use.
40
41
LARGE VOLUME PARENTERALS
REQUIREMENTS
Sterile, non pyrogenic, free from particulate matter
Volume 101- 1000ml
Single dose unit
No preservative
Clear solution except fat emulsion
Isotonic, but hypertonic also administered in TPN
TYPES OF LARGE VOLUME PARENTERALS
1.HYPER
ALIMENTATION
SOLUTIONS
2. CARDIOLPAGIC
SOLUTIONS
3. PERITONIAL
DIALYSIS SOLUTION 4. IRRIGATING SOLUTIONS
42
43
HYPERALIMENTATION SOLUTION
Admin. Of large amount of nutrients to patients who unable
to take food orally.
Formulation: mix. Of dextrose, amino acids , lipids,
electrolytes,& vitamines.
44
TOTAL PARENTERAL NUTRITION
Def. :A method of feeding patients by infusing a mixture
of all necessary nutrients into the circulatory system, thus
bypassing the GIT.
CONTENT SOURCES
1. calories Dextrose
2. Nitrogen Crystalline amino acids
3. Electrlyte Na , K, Cl , Po4,
4. Vitamines Water soluble & Fat soluble
5. Elements Traces of Zn, Cu, Mn, Cr
45
2. CARDIOLPLEGIC SOLUTIONS
Are LVP used in heart surgery to prevent injury to
myocardium during reperfusion, as well as to maintain
bloodless operating field.
Maintains the diastolic arrest.
Administerd in cold form.
Slightly alkaline to compensate metabolic acidosis,
Hypertonic
USE:
To minimize reperfusion injury resulting from tissue
edema.
46
3. PERITONEAL DIALYSIS SOLUTION
 Infused continuously into abdominal cavity, bathing
peritonium & are then continously withdrawn.
USE
Removal of toxic substances from body.
To aid & accelerate excretion normal.
To treat acute renal insufficiency.
47
4. IRRIGATING SOLUTIONS
To irrigate ,flush, & aid in cleaning body activities &
wounds.
Certain IV solution ( normal saline ) may be used as
irrigating solution , but solution designed as irrigating soln
should not be used parenterally.
Use: Treatment of serious wounds infused in to blood
stream.
4848
EXAMPLES OF LVP
49
Small volume parenterals
• Small volume intravenous injection is applied to an injection that is
packaged in containers labelled as containing 100 ml or less.
49
1. Solution:
2. Suspension:
3. Emulsion:
4. Dry powders:
solutions
• Typically used for delivering medications at a controlled infusion rate
• Most commonly solutions of 5% dextrose, normal saline, 45% normal
saline, or 5% dextrose with normal saline.
• Dextrose contributes glucose to meet energy needs and saline
contributes sodium, an electrolyte that maintains fluid balance and
cellular functions.
SUSPENSION
• They should be sterile, pyrogen free, stable,
re‐suspendable, syringeable, injectable, isotonic &
non‐irritating.
• They are usually administered by either subcutaneous
(S.C.) or intramuscular (I.M.) route.
• These suspensions usually contain between 0.5% and
5.0% solids & should have particle size less than 5
micrometer for I.M. or S.C. administration.
• Certain antibiotic preparations (For example procaine
Penicillin G) may contain up to 30% solids
51
• Advantages of Parental suspension
• It is better for the therapeutic use of drugs that are
insoluble in convention solvents.
• In this dosage from there is increased resistance to
hydrolysis & oxidation as drug is present in the solid
from.
• Formulation of controlled released drug is possible in
this dosage form.
• There is elimination of hepatic first pass effect.
52
Injectable Emulsion-
• An emulsion is a heterogenous dispersion of one
immiscible liquid in another.
• This inherently unstable system is made possible
through the use of an emulsifying agent, which prevent
coalescence of the dispersed droplet.
• Parenteral emulsion are rare because it is necessary
(and difficult) to achieve stable droplet of less than 1
micron meter to prevent emboli in blood vessels and it is
not usually necessary to achieve an emulsion for drug
administration. 53
54
Dry Powders
Purpose: To overcome the intrinsic instability of the drug, be
reconstitute before use.
• Production Method:
– Freeze-drying
–Aseptic crystallization and dry powder filling
– Spray-drying
• Pharmaceutical product development by
N K Jain.
• Theory and practice of industrial pharmacy by
Lachman and Leiberman.
• www. Google.com.
55
REFERENCE
56

More Related Content

What's hot

What's hot (20)

Hard Gelatin Capsule & Soft Gelatin Capsule
Hard Gelatin Capsule & Soft Gelatin CapsuleHard Gelatin Capsule & Soft Gelatin Capsule
Hard Gelatin Capsule & Soft Gelatin Capsule
 
Hard gelatin capsules ppt B
Hard gelatin  capsules ppt BHard gelatin  capsules ppt B
Hard gelatin capsules ppt B
 
Novel drug delivery system
Novel drug delivery systemNovel drug delivery system
Novel drug delivery system
 
Methods used for the manufacture of tablets
Methods used for the manufacture of tabletsMethods used for the manufacture of tablets
Methods used for the manufacture of tablets
 
Aerosols
AerosolsAerosols
Aerosols
 
TABLET COATING
TABLET COATINGTABLET COATING
TABLET COATING
 
Evaluation of capules
Evaluation of capulesEvaluation of capules
Evaluation of capules
 
Aerosols
AerosolsAerosols
Aerosols
 
Tablets
TabletsTablets
Tablets
 
Preformulation studies
Preformulation studiesPreformulation studies
Preformulation studies
 
Hard gelatin capsules - a detailed study
Hard gelatin capsules - a detailed studyHard gelatin capsules - a detailed study
Hard gelatin capsules - a detailed study
 
Tablet Evaluation
Tablet EvaluationTablet Evaluation
Tablet Evaluation
 
Pellets- Industrial pharmacy
Pellets- Industrial pharmacy   Pellets- Industrial pharmacy
Pellets- Industrial pharmacy
 
Filling of aerosol
Filling of aerosolFilling of aerosol
Filling of aerosol
 
Tablet coating defects
Tablet coating defectsTablet coating defects
Tablet coating defects
 
Capsules
CapsulesCapsules
Capsules
 
Containers and closure system of parenterals.
Containers and closure system of parenterals.Containers and closure system of parenterals.
Containers and closure system of parenterals.
 
Large and small volume parenterals preparations
Large and small volume parenterals preparationsLarge and small volume parenterals preparations
Large and small volume parenterals preparations
 
Evaluation of parenterals
Evaluation of parenteralsEvaluation of parenterals
Evaluation of parenterals
 
Formulation & Development of Aerosol
Formulation & Development of AerosolFormulation & Development of Aerosol
Formulation & Development of Aerosol
 

Viewers also liked

Viewers also liked (10)

parenterals....formulation & evaluation
parenterals....formulation & evaluationparenterals....formulation & evaluation
parenterals....formulation & evaluation
 
parenterals
parenteralsparenterals
parenterals
 
Parenterals bpk
Parenterals bpkParenterals bpk
Parenterals bpk
 
Parenteral preparation, equipments and layout
Parenteral preparation, equipments and layoutParenteral preparation, equipments and layout
Parenteral preparation, equipments and layout
 
Pharmaceutical water
Pharmaceutical waterPharmaceutical water
Pharmaceutical water
 
Isotonic solutions
Isotonic solutionsIsotonic solutions
Isotonic solutions
 
Sterile Dosage Forms
Sterile Dosage FormsSterile Dosage Forms
Sterile Dosage Forms
 
Isotonic solutions
Isotonic solutionsIsotonic solutions
Isotonic solutions
 
Parenteral production
Parenteral   productionParenteral   production
Parenteral production
 
Water for Pharmaceutical Purposes - New USP Requriements
Water for Pharmaceutical Purposes - New USP  RequriementsWater for Pharmaceutical Purposes - New USP  Requriements
Water for Pharmaceutical Purposes - New USP Requriements
 

Similar to Parenteral preparations

Chapter 8 parenterals
Chapter 8 parenteralsChapter 8 parenterals
Chapter 8 parenteralsAnn Bentley
 
Preparation & Stability of Large Volume Parenterals by PRINCE THAKUR
Preparation & Stability of Large Volume Parenterals by PRINCE THAKURPreparation & Stability of Large Volume Parenterals by PRINCE THAKUR
Preparation & Stability of Large Volume Parenterals by PRINCE THAKURPrinceThakur50
 
Preparation & stability of large & small volume parentrals
Preparation & stability of large & small volume parentralsPreparation & stability of large & small volume parentrals
Preparation & stability of large & small volume parentralsROHIT
 
QUALITY CONTROL OF PARENTERALS,STERILE PRODUCT
QUALITY CONTROL OF PARENTERALS,STERILE PRODUCTQUALITY CONTROL OF PARENTERALS,STERILE PRODUCT
QUALITY CONTROL OF PARENTERALS,STERILE PRODUCTMuhammad Arsal
 
Types of Parenteral Formulation
Types of Parenteral FormulationTypes of Parenteral Formulation
Types of Parenteral FormulationNIDHIBANSAL65
 
Parentral route and formulation
Parentral route and formulationParentral route and formulation
Parentral route and formulationNabina Kumar Patro
 
11 sterile dosage form
11 sterile dosage form11 sterile dosage form
11 sterile dosage formPradeep Patil
 
Sterile formulations – large and small volume parenterals (1).pptx
Sterile formulations – large and small volume parenterals (1).pptxSterile formulations – large and small volume parenterals (1).pptx
Sterile formulations – large and small volume parenterals (1).pptxMamtanaagar1
 
manufacturing of parenterals
manufacturing of parenteralsmanufacturing of parenterals
manufacturing of parenteralsSUPRAJA DEEP
 
SVP SEM- VIII 2020.pptx
SVP SEM- VIII 2020.pptxSVP SEM- VIII 2020.pptx
SVP SEM- VIII 2020.pptxvvengya
 
Parenteral Products
Parenteral ProductsParenteral Products
Parenteral ProductsKomal Sathe
 
extraction of bioactive compounds from plant sources using maceration process
extraction of bioactive compounds from plant sources using maceration processextraction of bioactive compounds from plant sources using maceration process
extraction of bioactive compounds from plant sources using maceration processNivaasvignopathy
 

Similar to Parenteral preparations (20)

Chapter 8 parenterals
Chapter 8 parenteralsChapter 8 parenterals
Chapter 8 parenterals
 
Manufacturing of water for injection
Manufacturing of water for injectionManufacturing of water for injection
Manufacturing of water for injection
 
Parenteral drug delivery
Parenteral drug deliveryParenteral drug delivery
Parenteral drug delivery
 
Preparation & Stability of Large Volume Parenterals by PRINCE THAKUR
Preparation & Stability of Large Volume Parenterals by PRINCE THAKURPreparation & Stability of Large Volume Parenterals by PRINCE THAKUR
Preparation & Stability of Large Volume Parenterals by PRINCE THAKUR
 
Preparation & stability of large & small volume parentrals
Preparation & stability of large & small volume parentralsPreparation & stability of large & small volume parentrals
Preparation & stability of large & small volume parentrals
 
QUALITY CONTROL OF PARENTERALS,STERILE PRODUCT
QUALITY CONTROL OF PARENTERALS,STERILE PRODUCTQUALITY CONTROL OF PARENTERALS,STERILE PRODUCT
QUALITY CONTROL OF PARENTERALS,STERILE PRODUCT
 
Types of Parenteral Formulation
Types of Parenteral FormulationTypes of Parenteral Formulation
Types of Parenteral Formulation
 
Parentrals
Parentrals Parentrals
Parentrals
 
Parentral route and formulation
Parentral route and formulationParentral route and formulation
Parentral route and formulation
 
11 sterile dosage form
11 sterile dosage form11 sterile dosage form
11 sterile dosage form
 
Parenterals
ParenteralsParenterals
Parenterals
 
Sterile formulations – large and small volume parenterals (1).pptx
Sterile formulations – large and small volume parenterals (1).pptxSterile formulations – large and small volume parenterals (1).pptx
Sterile formulations – large and small volume parenterals (1).pptx
 
Sterile Products & admixtures
Sterile Products & admixturesSterile Products & admixtures
Sterile Products & admixtures
 
Extraction and isolation of phytoconstituents
Extraction and isolation of phytoconstituentsExtraction and isolation of phytoconstituents
Extraction and isolation of phytoconstituents
 
manufacturing of parenterals
manufacturing of parenteralsmanufacturing of parenterals
manufacturing of parenterals
 
Parenterals
ParenteralsParenterals
Parenterals
 
SVP SEM- VIII 2020.pptx
SVP SEM- VIII 2020.pptxSVP SEM- VIII 2020.pptx
SVP SEM- VIII 2020.pptx
 
Depot preparations
Depot preparationsDepot preparations
Depot preparations
 
Parenteral Products
Parenteral ProductsParenteral Products
Parenteral Products
 
extraction of bioactive compounds from plant sources using maceration process
extraction of bioactive compounds from plant sources using maceration processextraction of bioactive compounds from plant sources using maceration process
extraction of bioactive compounds from plant sources using maceration process
 

Recently uploaded

Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxKatherine Villaluna
 
Benefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive EducationBenefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive EducationMJDuyan
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17Celine George
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfYu Kanazawa / Osaka University
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRATanmoy Mishra
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxheathfieldcps1
 
CapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapitolTechU
 
5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...CaraSkikne1
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxDr. Asif Anas
 
Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...raviapr7
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice documentXsasf Sfdfasd
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxKatherine Villaluna
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.raviapr7
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxiammrhaywood
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxraviapr7
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxraviapr7
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...Nguyen Thanh Tu Collection
 

Recently uploaded (20)

Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptxPractical Research 1: Lesson 8 Writing the Thesis Statement.pptx
Practical Research 1: Lesson 8 Writing the Thesis Statement.pptx
 
Benefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive EducationBenefits & Challenges of Inclusive Education
Benefits & Challenges of Inclusive Education
 
How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17How to Add a many2many Relational Field in Odoo 17
How to Add a many2many Relational Field in Odoo 17
 
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdfP4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
P4C x ELT = P4ELT: Its Theoretical Background (Kanazawa, 2024 March).pdf
 
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRADUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
DUST OF SNOW_BY ROBERT FROST_EDITED BY_ TANMOY MISHRA
 
The basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptxThe basics of sentences session 10pptx.pptx
The basics of sentences session 10pptx.pptx
 
CapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptxCapTechU Doctoral Presentation -March 2024 slides.pptx
CapTechU Doctoral Presentation -March 2024 slides.pptx
 
5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...5 charts on South Africa as a source country for international student recrui...
5 charts on South Africa as a source country for international student recrui...
 
Ultra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptxUltra structure and life cycle of Plasmodium.pptx
Ultra structure and life cycle of Plasmodium.pptx
 
Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...Patient Counselling. Definition of patient counseling; steps involved in pati...
Patient Counselling. Definition of patient counseling; steps involved in pati...
 
The Singapore Teaching Practice document
The Singapore Teaching Practice documentThe Singapore Teaching Practice document
The Singapore Teaching Practice document
 
Practical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptxPractical Research 1 Lesson 9 Scope and delimitation.pptx
Practical Research 1 Lesson 9 Scope and delimitation.pptx
 
Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.Drug Information Services- DIC and Sources.
Drug Information Services- DIC and Sources.
 
Finals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quizFinals of Kant get Marx 2.0 : a general politics quiz
Finals of Kant get Marx 2.0 : a general politics quiz
 
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptxAUDIENCE THEORY -- FANDOM -- JENKINS.pptx
AUDIENCE THEORY -- FANDOM -- JENKINS.pptx
 
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdfPersonal Resilience in Project Management 2 - TV Edit 1a.pdf
Personal Resilience in Project Management 2 - TV Edit 1a.pdf
 
Prelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quizPrelims of Kant get Marx 2.0: a general politics quiz
Prelims of Kant get Marx 2.0: a general politics quiz
 
Prescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptxPrescribed medication order and communication skills.pptx
Prescribed medication order and communication skills.pptx
 
Education and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptxEducation and training program in the hospital APR.pptx
Education and training program in the hospital APR.pptx
 
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
CHUYÊN ĐỀ DẠY THÊM TIẾNG ANH LỚP 11 - GLOBAL SUCCESS - NĂM HỌC 2023-2024 - HK...
 

Parenteral preparations

  • 1. 1
  • 3. 3 The term derived from Greek word ‛Para’ outside & ‛Enterone’ intestine. Parenterals are sterile solutions or suspension of drug in aqueous or oily vehicle. Parenteral drugs are administered directly in to the veins, muscles or under the skin , or more specialized tissues such as spinal cord. Term parenteral used for any drug/fluid whose delivery doesn’t utilize the alimentary canal for entering in to the body tissues.
  • 4. 4 • Stability • Sterility • Free from pyrogens & toxins • Free from foreign particles • Isotonic • Chemical purity
  • 5. 5 PARENTERAL ROUTES The term parenteral literally means to avoid the gut (gastrointestinal tract) and refers to any route of administration outside of or beside the alimentary tract. Thus, parenterals are injectable drugs that enter the body directly and are not required to be absorbed in the gastrointestinal tract before they show their effect. Parenteral routes of administration usually have a more rapid onset of action than other routes of administration.
  • 6. 6 1. Intravenous 2. Intramuscular 3. Subcutaneous 4. intradermal 5. Intra-arterial 6. Intracardiac 7. Intrathecal 8. Intracisternal 9. Peridural 10.Intraarticular 11.Intracerebral PARENTERAL ROUTES
  • 7. Intravenous • The injection of a drug directly into the patient's veins, resulting in the most rapid onset of action. 7
  • 8. 8 Intradermal The drug is injected into the top few layers of the skin. Ideally, the drug is placed within the dermis. Used for diagnostic agents. Subcutaneous The injection of the drug under the skin into the fatty layer, but not into the muscle. Absorption of the drug is rapid. Eg; insulin
  • 9. 9 Intramuscular Drugs are injected deeply into muscle tissue. If the drug is in aqueous (water) solution, absorption is rapid. However, if the drug is in an oily liquid or in the form of a suspension, it can prolong the release of the drug.
  • 10. 10
  • 11. 11
  • 12. 12 Useful for patients who cannot take drugs orally Rapid onset of action Useful for emergency situations Providing sustained drug delivery (implants, im depot inj) Avoid first pass metabolism Can inject drug directly in to a tissue (target drug delivery) Useful for delivering fluids, electrolytes, or nutrients (TPN) Can be done in hospitals, ambulatory infusion centers and home health care centers Complete bioavailability.
  • 13. 13 Pain on injection Difficult to reverse an administered drug’s effect. Sensitivity or allergic reaction at the site of injection. Requires strict control of sterility & non pyrogenicity than other formulation. Trained person is required. Require specialized equipment, devices, and techniques to prepare and administer drugs. More expensive and costly to produce.
  • 14. 14 1. Small volume parenterals (SVP) 2. Large volume parenterals (LVP)
  • 15. 15 USP defn: An injection that is packed in containers labeled as containing 100 ml or less. Defn: LVP are parenterals designed to provide :- Fluid Calories (dextrose solution ) Electrolytes Combenation of these Volume 101- 1000 ml
  • 16. 16 parameter SVP LVP volume 100 ml or less 101-1000 ml Routes IV, IM & SC IV- LVP & non IV- LVP Dosage unit Single or multiple Single preservative Used Not used Buffers Used Not used Formulation Soln, emulsion,suspension. Soln & o/w nutrient emulsion Isotonicity Not essential must Pyrogenicity Not essential must use Therapeutic & diagnostic Nutrition,detoxification, And during surgery
  • 17. 17 AQUEOUS VEHICLE : WATER FOR INJECTION (WFI) USP : Highly purified water used as a vehicle for injective preparations which will be subsequently sterilized. USP requirement include not more than 10 parts per million of total solids. pH of 5.0 – 7.0 . WFI may be prepared by either distillation or reverse osmosis.  Stored in chemically resistant tank.
  • 18. 18 BACTERIOSTATIC WATER FOR INJECTION This type of water used for making parenteral solutions prepared under aseptic conditions and not terminally sterilized. Need to meet USP sterility test. It can contain an added bacteriostatic agent when in containers of 30 ml or less.
  • 19. 19 STERILE WATER FOR INJECTION SWFI containing one or more suitable bacteriostatic agent.  multiple – dose containers not exceeding 30 ml. They are permitted to contain higher levels of solid than WFI because of possible leaching. Used for washing wounds , surgical incisions, or body tissues.
  • 20. 20 WATER MISCIBLE VEHICLES The number of solvents that are miscible with water has been used as a portion of a vehicle. Primarily to affect solubility of drugs and to reduce hydrolysis. Example: Ethyl alcohol, Liquid propelene glycol Glycerine Ethyl alcohol used in the case of cardiac glycoside.
  • 21. 21 NON – AQUEOUS VEHICLES Fixed oils (vegitable origin, liquid, and rancid resistance ,unsaturated, free fatty acid content ) Peanut oil Corn oil Cotton seed oil (depo-testosterone) Sesame oil Soyabean oil Ethyl oleate Isopropyl myristate.
  • 22. 22 ANTIBACTERIAL AGENTS These are added in multiple dose containers. To prevent microorganism growth Limitted concenteration of agents are used. Phenyl mercuric nitrate and thiomersol 0.01%. Benzethonium chloride & benzalkonium chloride 0.01%. Phenol & cresol 0.05%. Chlorobutanol 0.05%.
  • 23. 23 BUFFERS Added to maintain pH. To stabilize a solution from chemical degradation. Citrate and acetate buffer. Sodium benzoate and benzoic acid Sodium tartarate and tartaric acid Phosphate buffer.
  • 24. 24 ANTIOXIDENT To protect the formulation from oxidation Two types 1. Reducing agents Ascorbic acid Sodium bisulfite 0.01% Thiourea 2.Blocking agents Tocopherol
  • 25. 25 SURFACTANTS  Solubilise the active ingredient Polyoxythylene sorbitan monooleate & Sorbitan monooleate TONICITY AGENTS Need isotonic solution to avoid destruction of red blood cells, irritation, and tissue damage  More important for large volumes, rapidly administered, and extravascular injections  Reduces the pain on injection NaCl & KCl Dextrose Mannitol & Sorbitol Effect of different solutions on blood cells
  • 26. CHELATING AGENTS  To remove trace elements that catalyse oxidative degeneration Ethelene diamine tetra acetic acid 26 CO-SOLVENT  Improve solubility  Prevent potential for hydrolysis
  • 27. 27 BULKING AGENTS  For freeze dried preparations(solids) Mannitol Lactose ,sucrose Dextran . SUSPENDING AGENTS CMC, Methyl cellulose, Gelatin Sorbitol . EMULSIFYING AGENTS Lecithin Polysorbate 80
  • 28.  A clear and colorless liquid; odorless.  Water for injections is pyrogen -free.  It contains no added substance.  Water for injections is obtained from potable or Purified water by distillation in an apparatus.  The distillate is collected and stored in conditions designed to prevent growth of microorganisms and to avoid any other contamination. 28
  • 29. • The source water usually must be pretreated by one or a combination of following treatment: • Chemical softening, filtration, deionization, carbon absorption, or reverse osmosis purification. • There are three types of distillation still to produce water for injection. 1. Compression distillation 2. Multiple-effect still 3. Reverse osmosis 29
  • 30. • Vapor compression still is primarily designed for the production of large volumes of high purity distillate with low consumption of energy and water. • Vapor compression processes produce water 5 to 10 times more cost effectively than multiple effect distillers. • PROCEDURE: • Step 1: In a Vapor Compression still, the boiling process begins with both heating elements turned on. As the water in the boiling chamber reaches near boiling temperatures, the compressor turns on. 30
  • 31. • Step 2: In the compressor, the steam is pressurized, which raises the steam's temperature before it is routed through a special heat exchanger located inside the boiling chamber. • Step 3: The pressurized steam gives off its heat to the tap water inside the boiling chamber, causing this water to boil, which creates more steam. 31
  • 32. • Step 4: While the pressurized steam is giving up its latent heat, the steam will condense. One of the heating elements will cycle on and off periodically as needed. • Step 5: At this stage, the condensed steam is considered distilled water but is still very hot--only slightly cooler than boiling temperature. 32
  • 34. • It is also designed to conserve energy and water usage. • In principle, a series of single effect stills running at different pressures. • A series up to seven effect may be used, with the first effect operated at a highest pressure and the last effect at atmospheric pressure. • The capacity of still can be increased by adding effects. The quantity of distillate will also be affected by inlet steam pressure 34
  • 35. PRODEDURE:  Steam from the external source is used in the first effect to generate steam under pressure from feed water, it is used as a power source for second effect.  The steam used to drive the second effect condenses as it gives up its heat of vaporization and forms a distillate.  The process continues until the last effect, when the steam is at atmospheric pressure and must be condensed in a heat exchanger. 35
  • 36. 36
  • 37. REVERSE OSMOSIS: • The natural process of selective permeation of molecule through a semi-permeable membrane separate two aqueous solutions of different concentration is reversed. • Pressure, usually between 200 to 400 psig, is applied to overcome osmotic pressure and force pure water to penetrate through the membrane. • Membrane composed of cellulose esters or polyamides. 37
  • 38. 38 •. It provide effective rejection of contaminant molecules in raw water. •Sodium chloride is most difficult to remove. •Passage through two membranes in series is sometimes used to increase the efficiency of removal of small molecules. • ex. Aqua chem , Finn-aqua, Meco , Milipore etc.
  • 39. 39
  • 40. STORAGE AND DISTRIBUTION • Distillate is collected in holding tanks for subsequent use. • USP permit the storage of WFI at room temp. maximum for only about 24hr. • When the water can not be used at 80º c , heat exchangers must be installed to reduce the temperature at the point of use. 40
  • 41. 41 LARGE VOLUME PARENTERALS REQUIREMENTS Sterile, non pyrogenic, free from particulate matter Volume 101- 1000ml Single dose unit No preservative Clear solution except fat emulsion Isotonic, but hypertonic also administered in TPN
  • 42. TYPES OF LARGE VOLUME PARENTERALS 1.HYPER ALIMENTATION SOLUTIONS 2. CARDIOLPAGIC SOLUTIONS 3. PERITONIAL DIALYSIS SOLUTION 4. IRRIGATING SOLUTIONS 42
  • 43. 43 HYPERALIMENTATION SOLUTION Admin. Of large amount of nutrients to patients who unable to take food orally. Formulation: mix. Of dextrose, amino acids , lipids, electrolytes,& vitamines.
  • 44. 44 TOTAL PARENTERAL NUTRITION Def. :A method of feeding patients by infusing a mixture of all necessary nutrients into the circulatory system, thus bypassing the GIT. CONTENT SOURCES 1. calories Dextrose 2. Nitrogen Crystalline amino acids 3. Electrlyte Na , K, Cl , Po4, 4. Vitamines Water soluble & Fat soluble 5. Elements Traces of Zn, Cu, Mn, Cr
  • 45. 45 2. CARDIOLPLEGIC SOLUTIONS Are LVP used in heart surgery to prevent injury to myocardium during reperfusion, as well as to maintain bloodless operating field. Maintains the diastolic arrest. Administerd in cold form. Slightly alkaline to compensate metabolic acidosis, Hypertonic USE: To minimize reperfusion injury resulting from tissue edema.
  • 46. 46 3. PERITONEAL DIALYSIS SOLUTION  Infused continuously into abdominal cavity, bathing peritonium & are then continously withdrawn. USE Removal of toxic substances from body. To aid & accelerate excretion normal. To treat acute renal insufficiency.
  • 47. 47 4. IRRIGATING SOLUTIONS To irrigate ,flush, & aid in cleaning body activities & wounds. Certain IV solution ( normal saline ) may be used as irrigating solution , but solution designed as irrigating soln should not be used parenterally. Use: Treatment of serious wounds infused in to blood stream.
  • 49. 49 Small volume parenterals • Small volume intravenous injection is applied to an injection that is packaged in containers labelled as containing 100 ml or less. 49 1. Solution: 2. Suspension: 3. Emulsion: 4. Dry powders:
  • 50. solutions • Typically used for delivering medications at a controlled infusion rate • Most commonly solutions of 5% dextrose, normal saline, 45% normal saline, or 5% dextrose with normal saline. • Dextrose contributes glucose to meet energy needs and saline contributes sodium, an electrolyte that maintains fluid balance and cellular functions.
  • 51. SUSPENSION • They should be sterile, pyrogen free, stable, re‐suspendable, syringeable, injectable, isotonic & non‐irritating. • They are usually administered by either subcutaneous (S.C.) or intramuscular (I.M.) route. • These suspensions usually contain between 0.5% and 5.0% solids & should have particle size less than 5 micrometer for I.M. or S.C. administration. • Certain antibiotic preparations (For example procaine Penicillin G) may contain up to 30% solids 51
  • 52. • Advantages of Parental suspension • It is better for the therapeutic use of drugs that are insoluble in convention solvents. • In this dosage from there is increased resistance to hydrolysis & oxidation as drug is present in the solid from. • Formulation of controlled released drug is possible in this dosage form. • There is elimination of hepatic first pass effect. 52
  • 53. Injectable Emulsion- • An emulsion is a heterogenous dispersion of one immiscible liquid in another. • This inherently unstable system is made possible through the use of an emulsifying agent, which prevent coalescence of the dispersed droplet. • Parenteral emulsion are rare because it is necessary (and difficult) to achieve stable droplet of less than 1 micron meter to prevent emboli in blood vessels and it is not usually necessary to achieve an emulsion for drug administration. 53
  • 54. 54 Dry Powders Purpose: To overcome the intrinsic instability of the drug, be reconstitute before use. • Production Method: – Freeze-drying –Aseptic crystallization and dry powder filling – Spray-drying
  • 55. • Pharmaceutical product development by N K Jain. • Theory and practice of industrial pharmacy by Lachman and Leiberman. • www. Google.com. 55 REFERENCE
  • 56. 56